Tocilizumab or TCQ: A Study Drug for Pediatric Patients with COVID-19
Tocilizumab or TCQ is a study drug to help pediatric patients hospitalized with COVID-19. Research is needed to learn if it is safe and effective for these patients. The information we gain may aid futures patients.
- All genders
- All Ages
- Volunteers with special conditions
- In Person
Who can participate?
Gender: All genders
Age: All Ages
Volunteers: Volunteers with special conditions
Location: In Person
- Must be hospitalized with COVID-19
- 18 years old or younger
- Known allergic reaction to the study medicine
Will I be paid for my time?